Published in Cancer Res on April 01, 1972
Experimental manipulation of desmosome formation. J Cell Biol (1973) 1.03
Nuclear inclusions in alveolar epithelium of patients with fibrotic lung disorders. Am J Pathol (1979) 0.78
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum? Front Oncol (2017) 0.75
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
Smoking prevalence and attitudes toward smoking among Japanese physicians. JAMA (2001) 2.19
Neuropathological features of Japanese familial amyotrophic lateral sclerosis with p.N352S mutation in TARDBP. Neuropathol Appl Neurobiol (2014) 1.99
DNA polymerases I and II in regenerating rat liver and Morris hepatomas. Cancer Res (1973) 1.90
The nucleoids of rat liver cell microbodies. Fine structure and enzymes. J Cell Biol (1966) 1.89
The anaphase inhibitor Pds1 binds to the APC/C-associated protein Cdc20 in a destruction box-dependent manner. Curr Biol (2001) 1.88
Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chem (1970) 1.86
The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res (1972) 1.76
Principles of cartilage repair and regeneration. Clin Orthop Relat Res (1997) 1.75
Comparative high-resolution electrophoresis of tumor histones: variation in phosphorylation as a function of cell replication rate. Cancer Res (1972) 1.70
Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem (1981) 1.63
IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature (1975) 1.62
Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites. N Engl J Med (1974) 1.58
Abnormal microsomal cytochromes and electron transport in Morris hepatomas. J Biol Chem (1974) 1.57
Studies on the development, biochemistry, and biology of experimental hepatomas. Adv Cancer Res (1965) 1.54
Cell proliferation and tumor growth in hepatomas 3924A. Cancer Res (1971) 1.52
Evidence that the long-lifetime photointermediate of s-rhodopsin is a receptor for negative phototaxis in Halobacterium halobium. Biochem Biophys Res Commun (1985) 1.52
Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology (1999) 1.50
Microbodies and related particles. Morphology, biochemistry, and physiology. Int Rev Cytol (1969) 1.49
Mucosal prolapse syndrome: diagnosis with endoscopic US. Radiology (1994) 1.48
Morphogenesis and development of microbodies of hepatocytes of rats during pre- and postnatal growth. J Cell Biol (1968) 1.47
Glutaminase activities and growth rates of rat hepatomas. Cancer Res (1969) 1.40
Microbodies: constituent organelles of animal cells. Lab Invest (1972) 1.40
A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata. Br J Cancer (1973) 1.39
A preliminary report on the thymidine labeling indices and kinetics of cell proliferation in selected Morris hepatomas. Br J Cancer (1970) 1.36
Fine structure of transplantable hepatomas of the rat. J Natl Cancer Inst (1965) 1.31
Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol (2009) 1.31
The regulation of fatty acid biosynthesis in rat hepatomas. J Biol Chem (1968) 1.29
Ultrastructural changes in livers of two patients with hypervitaminosis A. Am J Pathol (1974) 1.29
Molecular basis of reduced albumin synthesis in Morris hepatoma 7777. Biochemistry (1978) 1.28
Mitochondrial malic enzymes. Mitochondrial NAD(P)+-dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas. J Biol Chem (1980) 1.28
Further studies on the deletion of the cholesterol feedback system in hepatomas. Cancer Res (1966) 1.24
Residual internal limiting membrane in epiretinal membrane surgery. Br J Ophthalmol (2009) 1.22
Application of positron emission tomography imaging to cancer screening. Br J Cancer (2000) 1.21
Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis. J Natl Cancer Inst (1976) 1.20
Chromosomes of "minimal deviation" hepatomas and some other transplantable rat tumors. Cancer Res (1967) 1.18
Ether-lipids, -glycerol phosphate dehydrogenase, and growth rate in tumors and cultured cells. Cancer Res (1972) 1.18
Gene expression profiles in Ciona intestinalis tailbud embryos. Development (2001) 1.18
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti (supplement). DNA Res (2000) 1.17
The heterogeneity of DNA polymerases in rat liver and hepatomas. Cancer Res (1968) 1.13
Phalloidin-induced cholestasis: a microfilament-mediated change in junctional complex permeability. Proc Natl Acad Sci U S A (1980) 1.13
Effect of triparanol and diethanolamine on the fine structure of hepatocytes and pancreatic acinar cells. Lab Invest (1965) 1.12
Systematic oscillations in metabolic activity in rat liver and in hepatomas. I. Morris hepatoma No. 7793. Cancer Res (1966) 1.10
RNA polymerases from a rat hepatoma. Partial purification and comparison of properties with corresponding liver enzymes. Biochim Biophys Acta (1976) 1.10
Nucleotide sequence homologies in nuclear and cytoplasmic ribonucleic acid from rat liver and hepatomas. Eur J Biochem (1968) 1.09
Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase. J Biol Chem (2001) 1.08
A comparison of the properties of pyruvate kinase from hepatoma 3924-A, normal liver and muscle. Life Sci (1969) 1.08
Kinetic, electrophoretic, and chromatographic studies on glucose-ATP phosphotransferases in rat hepatomas. Cancer Res (1969) 1.07
Superoxide dismutase and superoxide radical in Morris hepatomas. Cancer Res (1980) 1.07
AMPLE EXERCISE AND A MINIMUM OF FOOD AS MEASURES FOR CANCER PREVENTION? Science (1945) 1.07
Drug-induced and naturally occurring myeloid bodies. Lab Invest (1972) 1.06
Loss of feedback control of hydroxymethylglutaryl coenzyme A reductase in hepatomas. Proc Natl Acad Sci U S A (1971) 1.06
Rat ferritin isoproteins and their response to iron administration in a series of hepatic tumors and in normal and regenerating liver. Cancer Res (1970) 1.06
Identification and characterization of a novel inositol polyphosphate 5-phosphatase. J Biol Chem (2000) 1.06
Ultrastructural alterations of hepatic microbodies. Lab Invest (1966) 1.05
Comparison of in vivo translation rates and messenger RNA levels of alpha2U-globulin in rat liver and Morris hepatoma 5123D. Cancer Res (1976) 1.05
Inhibition of thymidine kinase activity in liver and hepatomas by TTP and d-CTP. Biochem Biophys Res Commun (1964) 1.05
Positive correlation between calmodulin content and hepatoma growth rates. Cancer Res (1982) 1.05
Two enzymes of serine metabolism in rat liver and hepatomas. Cancer Res (1970) 1.04
Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues. J Biol Chem (1982) 1.04
Polyribosomes in rat tissues. II. The polyribosome distribution in the minimal deviation hepatomas. Cancer Res (1965) 1.04
[Smoking and alcohol drinking behavior among Japanese adolescents--results from "Japan Know Your Body Study"]. Nihon Koshu Eisei Zasshi (1991) 1.04
Biosynthesis of N-acetylneuraminic acid in Morris hepatomas. Eur J Biochem (1973) 1.04
Base analysis of RNA by 3H postlabeling--a study of ribothymidine content and degree of base methylation of 4 S RNA. Biochim Biophys Acta (1974) 1.03
Metabolic regulation and enzyme alterations in the Morris hepatomas. Cancer Res (1968) 1.03
Mitochondrial poly(A) polymerase from a poorly differentiated hepatoma: purification and characteristics. Biochemistry (1975) 1.02
Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp Cell Res (2001) 1.02
Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology (1987) 1.01
Solid tumor models for the assessment of different treatment modalities: II: rapid, intermediate, and slow growing transplantable rat hepatomas. Life Sci (1976) 1.01
Lack of secretion of serum protein by transplanted rat hepatomas. Cancer Res (1966) 1.00
Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and of hepatomas in rats. Cancer Res (1980) 1.00
Beta-hydroxybutyrate dehydrogenase activity in liver and liver tumors. Cancer Res (1967) 0.99
Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer (2005) 0.98
Cytosol-modulated transport of messenger RNA from isolated nuclei. Cancer Res (1973) 0.98
Increased CTP synthetase activity in cancer cells. Nature (1978) 0.98
A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol (2009) 0.97
Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors. Cancer Res (1980) 0.97
Beneficial effect of basic fibroblast growth factor on the repair of full-thickness defects in rabbit articular cartilage. Arch Orthop Trauma Surg (1999) 0.97
Isolation and sequence analysis of two major leucine transfer ribonucleic acids (anticodon Mm-A-A) from a rat tumor, Morris hepatoma 5123D. Biochemistry (1980) 0.96
Behavior of opposing pathways of thymidine utilization in differentiating, regenerating, and neoplastic liver. Cancer Res (1971) 0.96
Loss of the cholesterol feedback system in the intact hepatoma-bearing rat. J Clin Invest (1972) 0.95
Meningitis caused by Bifidobacterium in an infant. Pediatr Infect Dis J (1988) 0.95
Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res (1976) 0.95
Occurrence and nature of O-alkyl and O-alk-I-enyl moieties of glycerol in lipids of Morris transplanted hepatomas and normal rat liver. Biochim Biophys Acta (1969) 0.95
Active proliferation of mouse hepatocytes in primary culture under defined conditions as compared to rat hepatocytes. Jpn J Cancer Res (1988) 0.94
A nuclear magnetic resonance study of water in two Morris hepatomas. Johns Hopkins Med J (1972) 0.94
The presence of an inhibitor of RNA sulfurtransferase in Morris hepatomas. Biochem Biophys Res Commun (1975) 0.94
Enzymatic and immunological studies on pyruvate carboxylase in livers and liver tumors. Cancer Res (1973) 0.94
Separable DNA polymerase activities in host liver and Morris hepatomas. Cancer Res (1973) 0.94
DNA synthesis and the effect of sucrose in nuclei of host liver and Morris hepatomas. Cancer Res (1971) 0.93
Pharbin, a novel inositol polyphosphate 5-phosphatase, induces dendritic appearances in fibroblasts. Biochem Biophys Res Commun (1999) 0.93
The effect of phenobarbital on drug metabolic enzyme activity, ultrastructure and growth of a "minimal deviation" hepatoma (Morris 7800). J Pharmacol Exp Ther (1967) 0.93
Kinetic characteristics of citrate influx and efflux with mitochondria from Morris hepatomas 3924A and 16. Cancer Res (1982) 0.93
Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2). Cancer Res (1976) 0.92
Recent trend of increase in proportion of low birthweight infants in Japan. Int J Epidemiol (2001) 0.92
Palliative gastrectomy for advanced gastric cancer. Hepatogastroenterology (2001) 0.92